↓ Skip to main content

Dove Medical Press

Targeting the A3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy

Overview of attention for article published in Drug Design, Development and Therapy, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#38 of 2,273)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
9 news outlets
patent
1 patent

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
38 Mendeley
Title
Targeting the A3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy
Published in
Drug Design, Development and Therapy, January 2019
DOI 10.2147/dddt.s195294
Pubmed ID
Authors

Shira Cohen, Pnina Fishman

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 24%
Student > Bachelor 8 21%
Student > Doctoral Student 4 11%
Student > Master 3 8%
Professor > Associate Professor 2 5%
Other 3 8%
Unknown 9 24%
Readers by discipline Count As %
Medicine and Dentistry 10 26%
Biochemistry, Genetics and Molecular Biology 6 16%
Pharmacology, Toxicology and Pharmaceutical Science 5 13%
Chemistry 3 8%
Immunology and Microbiology 2 5%
Other 4 11%
Unknown 8 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 66. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2023.
All research outputs
#646,237
of 25,516,314 outputs
Outputs from Drug Design, Development and Therapy
#38
of 2,273 outputs
Outputs of similar age
#14,650
of 447,446 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 32 outputs
Altmetric has tracked 25,516,314 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,273 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,446 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.